Senior Director, Consumer Omnichannel Marketing & Media

Senior Director, Consumer Omnichannel Marketing & Media

As the Senior Director, Consumer Omnichannel Marketing & Media, you will be a champion of Skyhawk’s culture and values while leading the integrated omnichannel marketing and media strategy for an upcoming launch. This pivotal role blends strategic vision, data-driven media leadership, and a deep understanding of consumer behavior to deliver an exceptional patient experience — from awareness through ongoing engagement.

The ideal candidate combines strong consumer marketing, digital and media planning & buying expertise with a mindset of curiosity and adaptability, proactively embracing AI tools to drive both efficiency and innovation. You will partner cross-functionally across Consumer, HCP, Patient Support Services and other cross-functional teams to bring to life a seamless, insight-based marketing ecosystem that empowers patients and drives brand success and will report to VP Marketing.

Responsibilities:

Strategic Leadership

• Own the consumer omnichannel marketing and media strategy for the launch — ensuring an integrated ecosystem across paid, owned, and earned channels including television, social media, CTV, CRM, website, display etc.


• Partner closely with Consumer & HCP Marketing on both ‘non personal’ and ‘personal’ promotion strategies, ensuring media strategy alignment with brand objectives.


• Translate brand objectives into data-driven, full-funnel media strategies that engage patients and caregivers throughout their journey.


• Partner closely with Consumer Marketing to ensure campaign and message pull-through across all media channels.

Innovation & Insight

• Identify and implement digital innovations (e.g., personalization, modular content, AI-enabled CRM, interactive tools) to enhance the patient experience.


• Evaluate performance through campaign measurement frameworks and optimize based on ROI, media mix modeling, and digital analytics.


• Identify and implement advanced analytics and precision targeting solutions to reach priority patient segments.


• Partner with Analytics and Insights team to turn insights into actionable growth strategies and executive-level reporting.
  
  

Team & Agency Leadership

• Manage agency relationships and significant media/OPEX budgets, ensuring efficient investment and measurable impact.


• Drive excellence across omnichannel execution areas, including CRM, patient journey design, website strategy, and experience tools (e.g., doctor finder, chatbots, patient apps).


• Lead and mentor a high-performing team, fostering development, innovation, and collaboration.

Requirements, Education, Experience & Skills:

• Bachelor’s degree


• 10+ years of progressive marketing experience, including significant pharma consumer and digital marketing expertise


• Minimum 3+ years omnichannel marketing experience within the pharmaceutical industry.


• Proven leadership of large, complex media planning and buying initiatives across digital and traditional channels.


• Deep understanding of patient journeys and omnichannel consumer engagement.


• Demonstrated success using data and analytics to optimize performance and inform strategy, including innovative patient targeting solutions.


• Experience leading cross-functional and agency teams and managing large budgets.


• Strong strategic, analytical, and communication skills with the ability to influence senior stakeholders.

Desired

• MBA


• Prior pharma launch experience


• Commercial experience in orphan disease areas


• Expertise in designing end-to-end patient experiences across digital, media, and patient support ecosystems.


• People management experience.

About Skyhawk

Skyhawk is committed to discovering, developing and commercializing small molecule therapeutics that modify RNA expression. We use our novel SkySTAR® platform (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA) to develop drug candidates directed toward targets for some of the world’s most intractable diseases including neurological conditions, cancer, and traditionally “undruggable” targets.